General Practice Doctors in Tiger, GA Accepting Medicare
1 General Practice doctors found. Showing 1 - 1
 Dr. Stephen W Jarrard, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 19 English St, Tiger, GA 30576 Phone: 706-782-3572 Fax: 706-782-1255 |
News Archive
ACE, Lilly Diabetes create "Diabetes Disaster Plan"
The Power of Prevention: Diabetes Disaster Plan is a checklist of essential items and tips to help diabetes patients prepare for the unexpected. Since Hurricane Katrina struck in 2005, ACE and Lilly Diabetes have worked together to create a comprehensive checklist of items for diabetes patients to prepare in anticipation of disaster.
FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI
Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
Diabetes disease management program helps Medicare patients reduce cost of medical care: Study
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
Haemonetics net revenue increases 8% to $235.8 million in Q2 fiscal 2014
Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.
KemPharm enters Supply Agreement with Johnson Matthey for KP201 hydrocodone prodrug for acute pain
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
› Verified 3 days ago